GRI

Latest SEC Filings & News for GRI

1 most recent filing and news item mentioning GRI. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/GRI/news?limit=20"

Pull GRI filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
RegulatoryJun 18, 2026Positive

GRI Bio Receives FDA Orphan Drug Designation for GRI-0621 in IPF

GRI Bio announced FDA Orphan Drug Designation for GRI-0621 (Tazarotene) to treat Idiopathic Pulmonary Fibrosis, a rare progressive lung disease. The designation provides potential seven-year U.S. market exclusivity, tax credits, and regulatory benefits that could accelerate devel

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.